glp-1 eating disorder Receptor Agonists and Research to Treat Overeating and Substance Use Disorders The Ozempic Era and Eating
Description
A comprehensive meta-analysis published in 2017 examining data from over 60,000 patients found no significant increase in pancreatic cancer risk associated with GLP-1 receptor agonist use
Learn more A complete guide to Contrave side effects what to expect during dose escalation, how to manage nausea, and when to contact your clinician
Understanding this timeline is crucial in managing client expectations and providing supportive care
Common GLP-1 Medications Some FDA-approved GLP-1 medications include: Semaglutide (Ozempic, Wegovy) Tirzepatide (Mounjaro also has GIP activity) Liraglutide (Saxenda, Victoza) These medications are administered via subcutaneous injection, typically once weekly
Although the GLP-1R antagonist exendin-9-39 (Ex9) is not used clinically, it has been used for research purposes because it blocks the endogenously released GLP-1
A: You may experience a natural loss of interest in alcohol because Tirzepatide targets the GLP-1 and GIP receptors in the brains reward centers
